Faron Pharmaceuticals Oy Stock Shares Owned By Insiders
| FARN Stock | 170.00 2.50 1.49% |
Faron Pharmaceuticals Oy fundamentals help investors to digest information that contributes to Faron Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Faron Stock. The fundamental analysis module provides a way to measure Faron Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Faron Pharmaceuticals stock.
Faron | Shares Owned By Insiders |
Faron Pharmaceuticals Oy Company Shares Owned By Insiders Analysis
Faron Pharmaceuticals' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Faron Pharmaceuticals Shares Owned By Insiders | 31.81 % |
Most of Faron Pharmaceuticals' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Faron Pharmaceuticals Oy is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 31.81499999999999% of Faron Pharmaceuticals Oy are shares owned by insiders. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The shares owned by insiders for all United Kingdom stocks is notably lower than that of the firm.
Faron Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Faron Pharmaceuticals' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Faron Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Faron Pharmaceuticals by comparing valuation metrics of similar companies.Faron Pharmaceuticals is currently under evaluation in shares owned by insiders category among its peers.
Faron Fundamentals
| Return On Equity | -39.61 | ||||
| Return On Asset | -0.7 | ||||
| Current Valuation | 163.6 M | ||||
| Shares Outstanding | 104.62 M | ||||
| Shares Owned By Insiders | 31.81 % | ||||
| Shares Owned By Institutions | 10.35 % | ||||
| Price To Book | 156.09 X | ||||
| Price To Sales | 16.21 X | ||||
| Gross Profit | 803 K | ||||
| EBITDA | (28.37 M) | ||||
| Net Income | (30.94 M) | ||||
| Total Debt | 13.11 M | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (23.81 M) | ||||
| Earnings Per Share | (0.31) X | ||||
| Target Price | 1009.02 | ||||
| Number Of Employees | 34 | ||||
| Beta | 0.33 | ||||
| Market Capitalization | 177.86 M | ||||
| Total Asset | 10.22 M | ||||
| Retained Earnings | (172.21 M) | ||||
| Working Capital | (6.14 M) | ||||
| Net Asset | 10.22 M |
About Faron Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Faron Pharmaceuticals Oy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Faron Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Faron Pharmaceuticals Oy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Faron Stock Analysis
When running Faron Pharmaceuticals' price analysis, check to measure Faron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Faron Pharmaceuticals is operating at the current time. Most of Faron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Faron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Faron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Faron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.